Form 8-K NEKTAR THERAPEUTICS For: Jul 31
http://archive.fast-edgar.com/20140731/ATA2G22CZZ22P2ZU229C2CZCSCRN2B22Z262
Filed on: July 31, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi reiterates buy rating on Nektar Therapeutics with $151 target
- Nextpower to Announce Second Quarter Fiscal 2027 Financial Results on October 28, 2026
- Wolfspeed Announces Conditional 30-Year, $1.5 Billion Loan Commitment from U.S. Department of War to Advance Domestic Wide Bandgap Supply Chain
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share